Table 5 Effect of timing of SIT initiation after IMC onset on outcomes among patients who had different response to steroid therapy
Covariate | Poor response to steroid | Good response to steroid | ||||
|---|---|---|---|---|---|---|
≤ 10 days N = 17 | > 10 days N = 24 | P | ≤ 10 days N = 23 | > 10 days N = 15 | P | |
Multiple hospitalization, No. (%) | 7 (41) | 16 (84) | 0.014 | 6 (32) | 6 (46) | 0.473 |
Failed steroid tapering after SIT, No. (%) | 8 (50) | 12 (50) | 1.000 | 1 (4) | 7 (47) | 0.003 |
Recurrent IMC, No. (%) | 4 (24) | 7 (29) | 0.736 | 4 (17) | 1 (7) | 0.630 |
Number of steroids tapering attempts, No. (%) | 0.532 | < 0.001 | ||||
1 | 6 (38) | 5 (21) | 20 (87) | 4 (27) | ||
2–4 | 10 (62) | 19 (79) | 3 (13) | 11 (73) | ||
Overall duration of steroids, mean days (SD) | 73 (43) | 96 (57) | 0.184 | 58 (34) | 59 (30) | 0.942 |
Duration of hospitalization, mean days (SD) | 12 (9) | 13 (8) | 0.545 | 9 (6) | 10 (8) | 0.571 |
Duration of symptoms, mean days (SD) | 39 (38) | 57 (45) | 0.179 | 17 (24) | 39 (30) | 0.016 |